University of Manitoba
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1877-02-28
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.umanitoba.ca
Amphotericin-B and Voriconazole for Pulmonary Blastomycosis
- First Posted Date
- 2014-11-05
- Last Posted Date
- 2020-09-29
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 2
- Registration Number
- NCT02283905
- Locations
- 🇨🇦
St. Boniface General Hospital, Winnipeg, Manitoba, Canada
Acetylamantadine Excretion by Cancer Patients
- Conditions
- Cancer
- Interventions
- First Posted Date
- 2014-10-29
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 120
- Registration Number
- NCT02277938
- Locations
- 🇨🇦
St. Boniface Hospital, Winnipeg, Manitoba, Canada
Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis
Not Applicable
Completed
- Conditions
- Renal Failure Chronic Requiring HemodialysisEnd-stage Renal Disease
- Interventions
- Behavioral: Exercise Rehabilitation
- First Posted Date
- 2014-10-08
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 133
- Registration Number
- NCT02259413
- Locations
- 🇨🇦
Seven Oaks General Hospital, Winnipeg, Manitoba, Canada
🇨🇦Health Sciences Centre, Winnipeg, Manitoba, Canada
🇨🇦St. Boniface Hospital, Winnipeg, Manitoba, Canada
Evaluation of Carbothera in the Treatment of Foot Ulcers
Not Applicable
- Conditions
- Skin UlcerationCritical Lower Limb IschemiaFoot UlcerCritical Limb Ischemia
- Interventions
- Procedure: Non-CO2-Enriched Tap WaterProcedure: CO2-Enriched Tap Water (Carbothera)
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2015-10-30
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 40
- Registration Number
- NCT02239419
- Locations
- 🇨🇦
Health Sciences Centre- Rehabilitation Hospital, Winnipeg, Manitoba, Canada
🇨🇦St. Boniface General Hospital, Winnipeg, Manitoba, Canada
Preoperative Oral Dexamethasone to Improve Recovery After Surgery
Phase 2
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2014-09-09
- Last Posted Date
- 2014-09-09
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 80
- Registration Number
- NCT02234466
- Locations
- 🇨🇦
Health Science Centre, Winnipeg, Manitoba, Canada
Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents
Phase 2
Completed
- Conditions
- TYPE 2 DIABETESMETABOLIC SYNDROMENAFLD
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Resveratrol
- First Posted Date
- 2014-08-15
- Last Posted Date
- 2017-05-05
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 10
- Registration Number
- NCT02216552
- Locations
- 🇨🇦
Children's Hospital Research Institute of Manitoba/University of Manitoba, Winnipeg, Manitoba, Canada
Diabetes Intervention Program for Adolescents With Persistent High HA1c
Not Applicable
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Behavioral: motivational interviewing group
- First Posted Date
- 2014-08-08
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 20
- Registration Number
- NCT02212158
- Locations
- 🇨🇦
Diabetes Resource for Children and Adolescence, Winnipeg, Manitoba, Canada
EXIT: Prospective Study of the Response to Exercise
Completed
- Conditions
- Liver FatType 2 Diabetes
- Interventions
- Other: Acute release of irisin after a single exercise session.
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 15
- Registration Number
- NCT02204670
- Locations
- 🇨🇦
The Manitoba Institute of Child Health, Winnipeg, Canada
Preventing Early Dialysis Starts
Not Applicable
Completed
- Conditions
- Chronic Kidney Disease
- Interventions
- Other: Active Knowledge Translation Intervention
- First Posted Date
- 2014-07-08
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 55
- Registration Number
- NCT02183987
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
🇨🇦University of Manitoba, Winnipeg, Manitoba, Canada
Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial
Not Applicable
Completed
- Conditions
- GlycosadeGlycogen Storage Disorder Type 1CornstarchHypoglycemia
- Interventions
- Dietary Supplement: Glycosade
- First Posted Date
- 2014-06-26
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 4
- Registration Number
- NCT02176096
- Locations
- 🇨🇦
Chrildren's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada
© Copyright 2025. All Rights Reserved by MedPath